Not applicableStudy completedNCT02434484What this trial is testingSymbenda Post-Marketing Surveillance (PMS)Who this might be right forLymphoma, Non-HodgkinLymphocytic LeukemiaMultiple Myeloma Eisai Korea Inc. 84
Not applicableStudy completedNCT01611298What this trial is testingDonor-Derived Humoral Immunity, Hematopoietic Stem Cell Transplantation, TARWho this might be right forAcute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaChronic Myelogenous Leukemia+3 more Robert Krance 7
Not applicableLooking for participantsNCT05708716What this trial is testingDiet and Cognitive Training in Hematologic Cancer SurvivorsWho this might be right forCognitive ImpairmentHematologic Malignancy University of Alabama at Birmingham 80
Large-scale testing (Phase 3)Ended earlyNCT00014326What this trial is testingInvolved-Field Radiation Therapy in Treating Patients With Previously Untreated Stage I or Stage II Low-Grade Non-Hodgkin's LymphomaWho this might be right forLymphoma European Organisation for Research and Treatment of Cancer - EORTC 204
Testing effectiveness (Phase 2)Study completedNCT00867529What this trial is testingRituximab in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant for Relapsed or Refractory B-cell LymphomaWho this might be right forB-cell Adult Acute Lymphoblastic LeukemiaB-cell Childhood Acute Lymphoblastic LeukemiaB-cell Chronic Lymphocytic Leukemia+35 more Fred Hutchinson Cancer Center 63
Not applicableLooking for participantsNCT07751783What this trial is testingDevelopment and Dissemination of Exercise Prescription and Intervention for Cancer PopulationsWho this might be right forCancerCancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma)Lung Cancer (Non-Small Cell)+2 more Kaohsiung Medical University Chung-Ho Memorial Hospital 150
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06667973What this trial is testingEfficacy of Gilteritinib in Combination With FLAI as Induction Therapy of FLT3-positive Acute Myeloid LeukemiaWho this might be right forAcute Myeloid LeukemiaFLT3 Gene MutationAdult AML+1 more Gruppo Italiano Malattie EMatologiche dell'Adulto 80
Early research (Phase 1)Looking for participantsNCT06649227What this trial is testingStudy Investigating the Safety of CD19 CAR-T Cells in Relapsed/Refractory AML Expressing CD19Who this might be right forRelapsed Adult AML University Hospital, Lille 5
Testing effectiveness (Phase 2)Study completedNCT00005942What this trial is testingLiposomal Daunorubicin and SU5416 in Treating Patients With Hematologic Cancer That Has Not Responded to Initial TherapyWho this might be right forChronic Myelomonocytic LeukemiaPreviously Treated Myelodysplastic SyndromesRecurrent Adult Acute Myeloid Leukemia+2 more National Cancer Institute (NCI) 37
Early research (Phase 1)Study completedNCT02996773What this trial is testingHaploidentical BMT With Post-Transplant Cyclophosphamide and BendamustineWho this might be right forAcute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaMyelodysplastic Syndromes+10 more University of Arizona 50
Early research (Phase 1)Study completedNCT00003294What this trial is testingChemotherapy Given With Amifostine and Filgrastim in Treating Patients With Recurrent or Metastatic CancerWho this might be right forLeukemiaLymphomaUnspecified Adult Solid Tumor, Protocol Specific Roswell Park Cancer Institute 24
Testing effectiveness (Phase 2)Study completedNCT02743351What this trial is testingStudy of ProTmune for Allogeneic HCT in Adult Patients With Hematologic MalignanciesWho this might be right forHematologic MalignanciesAcute Myeloid LeukemiaAcute Lymphoblastic Leukemia+3 more Fate Therapeutics 96
Testing effectiveness (Phase 2)Ended earlyNCT01500161What this trial is testingPooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-MatchWho this might be right forAcute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Lymphocytic Leukemia+6 more Texas Oncology Cancer Center 1
Testing effectiveness (Phase 2)Looking for participantsNCT06580002What this trial is testingRepurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot TrialWho this might be right forBreast CancerSarcomaGastric Cancer+19 more University of California, Irvine 75
Testing effectiveness (Phase 2)Study completedNCT04605666What this trial is testingCD19-CAR-T2 Cells for CD19 Positive B Cell MalignanciesWho this might be right forB Cell LeukemiaB Cell Lymphoma Nanfang Hospital, Southern Medical University 77
Early research (Phase 1)UnknownNCT04008251What this trial is testingHumanized CD19 Chimeric Antigen Receptor (CAR)-Modified T Cell Therapy in Treating Patients With B-cell MalignanciesWho this might be right forAcute Lymphoblastic LeukemiaB Cell Lymphoma Wuhan Sian Medical Technology Co., Ltd 10
Testing effectiveness (Phase 2)Study completedNCT00006251What this trial is testingFludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic CancerWho this might be right forAcute Undifferentiated LeukemiaAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell Lymphoma+61 more Fred Hutchinson Cancer Center 21
Not applicableActive Not RecruitingNCT06479954What this trial is testingNon Interventional Study to Investigate the Safety and Effectiveness in Patients With Relapsed and Refractory Multiple Myeloma Treated With Elranatamab Under the Actual Use.Who this might be right forRelapsed and Refractory Multiple Myeloma (RRMM) Pfizer 1
Early research (Phase 1)Ended earlyNCT03465540What this trial is testingSafety, Tolerability, Pharmacokinetics and Efficacy of AMG 397 in Subjects With Selected Relapsed or Refractory Hematological MalignanciesWho this might be right forMultiple MyelomaAcute Myeloid LeukemiaNon-Hodgkins Lymphoma+4 more Amgen 24
Early research (Phase 1)UnknownNCT03383952What this trial is testingA Clinical Study of CD19 Targeted CAR-T for Patients With CD19+ Lymphoma and LeukemiaWho this might be right forB Cell LeukemiaB Cell Lymphoma Immune Cell, Inc. 20